Johnson & Johnson’s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense. The $21.3 billion deal will give Johnson & Johnson a leading position in the main orthopedic device markets. …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
Johnson & Johnson (JNJ.N) shares have beaten the group in 2016 as investors turn to safety in rocky equity markets. But with the stock price now hovering near its $110.35 record high, that strategy may be in doubt. J&J shares already …
The stock price rise over the year and the results announced Tuesday probably will help Gorsky's personal finances. According to the JNJ proxy statement filed with the Securities and Exchange Commission on March 12, 2014, Gorsky …
Unexpectedly strong earnings reports from heavyweights like Mattel and Johnson & Johnson streamed in on Tuesday, …
Pfizer shares closed 37 cents, or 1.6 percent, higher at $23.13 each, while Johnson & Johnson stock fell $1.11, or 1.8 percent, to $60.21 a share.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Schlumberger (SLB) and PayPal (PYPL). …
Ben Bernanke, clearly no Keynesian, recently delivered a speech entitled "Economic Prospects for the Long Run." What, then, would he make of the extremely short-term stock gyrations caused by his every muttering? The Dow (^DJI), up …
CHICAGO, Oct. 9, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIS, JNJ, LLY, MZOR, …